| Authors: |
Carr ALJ; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada. acarr1@ualberta.ca., Sutton H; Diabetes and Inflammation Laboratory, Centre for Human Genetics, Nuffield Department of Medicine, Bukhman Centre for Research Excellence in Type 1 Diabetes, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Agesen RM; Novo Nordisk A/S, Søborg, Denmark., Bonifacio E; Center for Regenerative Therapies Dresden (CRTD), Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Bosi E; Diabetes Research Institute, San Raffaele Hospital, Milan, Italy.; San Raffaele Vita Salute University, Milan, Italy., Gillard P; Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.; Research Foundation Flanders-FWO, Leuven, Belgium., Swaby R; Diabetes and Inflammation Laboratory, Centre for Human Genetics, Nuffield Department of Medicine, Bukhman Centre for Research Excellence in Type 1 Diabetes, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Vercauteren J; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium., Besser REJ; Diabetes and Inflammation Laboratory, Centre for Human Genetics, Nuffield Department of Medicine, Bukhman Centre for Research Excellence in Type 1 Diabetes, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. rachel.besser@well.ox.ac.uk.; Department of Paediatrics, University of Oxford, Oxford, UK. rachel.besser@well.ox.ac.uk. |
